TuHURA Biosciences, Inc./NV — Form 8-K
Filed August 21, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
TuHURA Biosciences filed an 8-K on 2026-08-20 disclosing creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03. The filing provides no specific dollar amounts, counterparty names, dates, percentages, or share counts—only structural notification that such an obligation exists. Full details of the obligation's nature, size, and terms are not disclosed in this filing extract.
Why this rating
Item 2.03 filing signals a material event but lacks concrete terms; cannot assess dollar impact relative to $111M market cap without specifics. Routine disclosure.
Extracted items
- 2.03 material obligation
- 9.01 exhibits
See more from August 21, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.